|
1
|
Tran MM, Mirza FN, Lee AC, Goldbach HS, Libby TJ, Wisco OJ. Dermatologic findings associated with semaglutide use: A scoping review. J Am Acad Dermatol 2024:S0190-9622(24)00532-2. [PMID: 38554940 DOI: 10.1016/j.jaad.2024.03.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2024] [Revised: 03/05/2024] [Accepted: 03/12/2024] [Indexed: 04/02/2024]
Affiliation(s)
- Megan M Tran
- Warren Alpert Medical School, Brown University, Providence, Rhode Island
| | - Fatima N Mirza
- Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island
| | | | - Hayley S Goldbach
- Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island
| | - Tiffany J Libby
- Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island
| | - Oliver J Wisco
- Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island
| |
Collapse
|
|
2
|
Mirza FN, Lim RK, Yumeen S, Wahood S, Zaidat B, Shah A, Tang OY, Kawaoka J, Seo SJ, DiMarco C, Muglia J, Goldbach HS, Wisco O, Qureshi AA, Libby TJ. Performance of Three Large Language Models on Dermatology Board Examinations. J Invest Dermatol 2024; 144:398-400. [PMID: 37541614 DOI: 10.1016/j.jid.2023.06.208] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2023] [Accepted: 06/27/2023] [Indexed: 08/06/2023]
Affiliation(s)
- Fatima N Mirza
- Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
| | - Rachel K Lim
- Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA; The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
| | - Sara Yumeen
- Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
| | - Samer Wahood
- The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
| | - Bashar Zaidat
- Icahn School of Medicine at Mount Sinai, New York City, New York, USA
| | - Asghar Shah
- The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
| | - Oliver Y Tang
- Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
| | - John Kawaoka
- Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
| | - Su-Jean Seo
- Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
| | - Christopher DiMarco
- Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
| | - Jennie Muglia
- Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
| | - Hayley S Goldbach
- Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
| | - Oliver Wisco
- Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
| | - Abrar A Qureshi
- Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
| | - Tiffany J Libby
- Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
| |
Collapse
|
|
3
|
Omer M, Trepanowski N, Yumeen S, Mirza FN, Goldbach HS, Joshipura D, Woo SB, Nuovo GJ, Robinson-Bostom L. Focal epithelial hyperplasia associated with human papillomavirus-13 in a healthy Haitian adult. JAAD Case Rep 2023; 42:52-55. [PMID: 38053542 PMCID: PMC10694523 DOI: 10.1016/j.jdcr.2023.09.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/07/2023] Open
Affiliation(s)
- Mohamed Omer
- Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island
- Department of Pathology, Warren Alpert Medical School of Brown University, Providence, Rhode Island
| | - Nicole Trepanowski
- Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island
- Boston University School of Medicine, Boston, Massachusetts
| | - Sara Yumeen
- Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island
| | - Fatima N. Mirza
- Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island
| | - Hayley S. Goldbach
- Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island
| | - Deep Joshipura
- Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island
| | - Sook-Bin Woo
- Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts
- Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, Boston, Massachusetts
| | - Gerard J. Nuovo
- Department of Pathology, Ohio State University Medical Center, Columbus, Ohio
- GnomeDX, Powell, Ohio
| | - Leslie Robinson-Bostom
- Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island
| |
Collapse
|
|
4
|
Trehan I, Goldbach HS, LaGrone LN, Meuli GJ, Wang RJ, Maleta KM, Manary MJ. Antibiotics as part of the management of severe acute malnutrition. Malawi Med J 2016; 28:123-130. [PMID: 27895846 PMCID: PMC5117002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023] Open
Abstract
BACKGROUND Severe acute malnutrition contributes to 1 million deaths among children annually. Adding routine antibiotic agents to nutritional therapy may increase recovery rates and decrease mortality among children with severe acute malnutrition treated in the community. METHODS In this randomized, double-blind, placebo-controlled trial, we randomly assigned Malawian children, 6 to 59 months of age, with severe acute malnutrition to receive amoxicillin, cefdinir, or placebo for 7 days in addition to ready-to-use therapeutic food for the outpatient treatment of uncomplicated severe acute malnutrition. The primary outcomes were the rate of nutritional recovery and the mortality rate. RESULTS A total of 2767 children with severe acute malnutrition were enrolled. In the amoxicillin, cefdinir, and placebo groups, 88.7%, 90.9%, and 85.1% of the children recovered, respectively (relative risk of treatment failure with placebo vs. amoxicillin, 1.32; 95% confidence interval [CI], 1.04 to 1.68; relative risk with placebo vs. cefdinir, 1.64; 95% CI, 1.27 to 2.11). The mortality rates for the three groups were 4.8%, 4.1%, and 7.4%, respectively (relative risk of death with placebo vs. amoxicillin, 1.55; 95% CI, 1.07 to 2.24; relative risk with placebo vs. cefdinir, 1.80; 95% CI, 1.22 to 2.64). Among children who recovered, the rate of weight gain was increased among those who received antibiotics. No interaction between type of severe acute malnutrition and intervention group was observed for either the rate of nutritional recovery or the mortality rate. CONCLUSIONS The addition of antibiotics to therapeutic regimens for uncomplicated severe acute malnutrition was associated with a significant improvement in recovery and mortality rates. (Funded by the Hickey Family Foundation and others; ClinicalTrials.gov number, NCT01000298.).
Collapse
Affiliation(s)
- Indi Trehan
- Department of Pediatrics, Washington University in St. Louis, St. Louis, Missouri, U.S.A.; Department of Paediatrics and Child Health, College of Medicine, University of Malawi, Blantyre, Malawi
| | - Hayley S Goldbach
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A
| | - Lacey N LaGrone
- Department of Surgery, University of Washington, Seattle, Washington, U.S.A
| | - Guthrie J Meuli
- Department of Pediatrics, Washington University in St. Louis, St. Louis, Missouri, U.S.A
| | - Richard J Wang
- Department of Medicine, Weill Cornell Medical College, Cornell University, New York, New York, U.S.A
| | - Kenneth M Maleta
- Department of Community Health, College of Medicine, University of Malawi, Blantyre, Malawi
| | - Mark J Manary
- Department of Pediatrics, Washington University in St. Louis, St. Louis, Missouri, U.S.A.; Department of Community Health, College of Medicine, University of Malawi, Blantyre, Malawi; U.S. Department of Agriculture/Agricultural Research Service, Children's Nutrition Research Center, Baylor College of Medicine, Houston, Texas, U.S.A
| |
Collapse
|
|
5
|
Abstract
BACKGROUND Severe acute malnutrition contributes to 1 million deaths among children annually. Adding routine antibiotic agents to nutritional therapy may increase recovery rates and decrease mortality among children with severe acute malnutrition treated in the community. METHODS In this randomized, double-blind, placebo-controlled trial, we randomly assigned Malawian children, 6 to 59 months of age, with severe acute malnutrition to receive amoxicillin, cefdinir, or placebo for 7 days in addition to ready-to-use therapeutic food for the outpatient treatment of uncomplicated severe acute malnutrition. The primary outcomes were the rate of nutritional recovery and the mortality rate. RESULTS A total of 2767 children with severe acute malnutrition were enrolled. In the amoxicillin, cefdinir, and placebo groups, 88.7%, 90.9%, and 85.1% of the children recovered, respectively (relative risk of treatment failure with placebo vs. amoxicillin, 1.32; 95% confidence interval [CI], 1.04 to 1.68; relative risk with placebo vs. cefdinir, 1.64; 95% CI, 1.27 to 2.11). The mortality rates for the three groups were 4.8%, 4.1%, and 7.4%, respectively (relative risk of death with placebo vs. amoxicillin, 1.55; 95% CI, 1.07 to 2.24; relative risk with placebo vs. cefdinir, 1.80; 95% CI, 1.22 to 2.64). Among children who recovered, the rate of weight gain was increased among those who received antibiotics. No interaction between type of severe acute malnutrition and intervention group was observed for either the rate of nutritional recovery or the mortality rate. CONCLUSIONS The addition of antibiotics to therapeutic regimens for uncomplicated severe acute malnutrition was associated with a significant improvement in recovery and mortality rates. (Funded by the Hickey Family Foundation and others; ClinicalTrials.gov number, NCT01000298.).
Collapse
Affiliation(s)
- Indi Trehan
- Department of Pediatrics, Washington University in St. Louis, St. Louis, MO 63110, USA
| | | | | | | | | | | | | |
Collapse
|